XML 44 R35.htm IDEA: XBRL DOCUMENT
v3.25.2

Collaborations, Licensing and Other Arrangements (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |
Schedule of Total Revenue from Collaboration and Services | Revenue from collaborations and services were as follows (in thousands):
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
UT CSA(1) |  | $ | 22,224 |  |  | $ | 25,978 |  |  | $ | 51,042 |  |  | $ | 50,442 |
Amphastar co-promotion agreement |  |  | 500 |  |  |  | — |  |  |  | 1,000 |  |  |  | — |
Cipla License and Distribution Agreement |  |  | 37 |  |  |  | 36 |  |  |  | 73 |  |  |  | 73 |
Other |  |  | 84 |  |  |  | — |  |  |  | 106 |  |  |  | — |
UT License Agreement |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 347 |
Total revenue from collaborations and services |  | $ | 22,845 |  |  | $ | 26,014 |  |  | $ | 52,221 |  |  | $ | 50,862 |
_________________________ (1) Amounts consist of revenue recognized for Manufacturing Services to UT for the periods presented.
United Therapeutics Corporation |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |
Schedule of Total Revenue from Collaboration and Services | Total revenue from UT was as follows (in thousands):
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Revenue from UT |  |  |  |  |  |  |  |  |  |  |  |
Royalties(1) |  | $ | 31,228 |  |  | $ | 25,592 |  |  | $ | 61,233 |  |  | $ | 48,243 |
UT CSA |  |  | 22,224 |  |  |  | 25,978 |  |  |  | 51,042 |  |  |  | 50,442 |
UT License Agreement |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 347 |
Total revenue from UT |  | $ | 53,452 |  |  | $ | 51,570 |  |  | $ | 112,275 |  |  | $ | 99,032 |
_________________________ (1) Amounts consist of royalties associated with the UT License Agreement. The contract assets related to the royalties is included in prepaid expense and other current assets in the condensed consolidated balance sheets.
UT CSA |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |
Schedule of Total Revenue from Collaboration and Services | The portion of revenue related to each deliverable included in UT CSA revenue (in thousands) is as follows:
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
UT CSA Revenue |  |  |  |  |  |  |  |  |  |  |  |
Sale of product(1) |  | $ | 18,704 |  |  |  | 21,400 |  |  |  | 43,818 |  |  |  | 42,943 |
Recognition of previously deferred revenue |  |  | 2,654 |  |  |  | 3,611 |  |  |  | 6,066 |  |  |  | 6,088 |
Other agreements |  |  | 866 |  |  |  | 967 |  |  |  | 1,158 |  |  |  | 1,411 |
Total UT CSA revenue |  | $ | 22,224 |  |  | $ | 25,978 |  |  | $ | 51,042 |  |  | $ | 50,442 |
_________________________ Sale of product included revenue related to fully reimbursable costs associated with product sales and other miscellaneous charges of $1.2 million and $2.9 million for the three and six months ended June 30, 2024, and no ne in 2025

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UnitedTherapeuticsCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mnkd_UTCSAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |